Pre-Markets Keep Optimistic, Earnings Beats for JNJ, PG, ALLY & More
Werte in diesem Artikel
Wednesday, January 22, 2025Ahead of today’s regular stock market trading session, pre-market futures are picking up where they left off Tuesday afternoon: higher. Continued optimism for a pro-growth Trump administration are sending major indexes to loftier reaches: the Dow is currently +145 points (+0.33%), the S&P 500 is +34 (+0.56%) and the Nasdaq +219 points (+1.01%). The small-cap Russell 2000 is slightly lower today (-0.14%) after leading the indexes yesterday.As we’ve mentioned earlier this week in this space, we are light on economic prints in this holiday-shortened week. Last week brought us all-important CPI, PPI, Retail Sales and Housing Starts data, while next month concludes with two potentially impactful reports: Personal Consumption Expenditures (PCE) and a new interest rate meeting from the Fed, both on Friday. This week, we’ll see U.S. Leading Economic Indicators (LEI) after today’s opening bell, but nothing else on the economic-report agenda.Q4 Earnings Roundup: JNJ, PG, ALLY & MoreIt is, however, an important week for calendar Q4 earnings results, including a Netflix NFLX report Tuesday afternoon that was its most positive in recent memory. This morning, if it’s in your bathroom cabinet, its company is probably reporting earnings this morning.Johnson & Johnson JNJ shares are down slightly in today’s pre-market, after beating estimates slightly on both top and bottom lines for Q4 this morning: earnings of $2.04 per share outpaced the Zacks consensus by 4 cents, while revenues for the quarter reached $22.52 billion — for a modest +0.06% increase over estimates. But revenue guidance is coming in a bit light, sending the stock to give back the +2.44% it has earned year to date. For more on JNJ’s earnings, click here.Check out the updated Zacks Earnings Calendar here.Procter & Gamble PG also put up a modest beat on its bottom line — for fiscal Q2, in its case — to $1.88 per share from $1.86 expected, on revenues of $21.88 billion, which outperformed the Zacks consensus by +1.33%. Demand for household goods is reportedly up; the stock is well off its early December all-time high, but still +3.3% in today’s pre-market. For more on PG’s earnings, click here.Ally Financial ALLY shares are up +10% ahead of today’s open, as its Q4 report this morning easily surpassed expectations on its bottom line: 78 cents per share versus 59 cents projected. Revenues of $2.1 billion beat the Zacks consensus of $2.07 billion. The bank boasted a +95% customer retention rate in the quarter, adding to its +6% gains made, year to date.Fiber-optics major Amphenol APH posted solid beats on both top and bottom lines this morning, as Q4 earnings of 55 cents per share surpassed estimates by a solid nickel, and revenues of $4.32 billion swept past the $4.03 billion in the Zacks consensus, and was up +29.8% year over year. Shares are doubling their +4.9% gains year to date on the earnings news this morning for the Zacks Rank #2 (Buy)-rated stock.Questions or comments about this article and/or author? Click here>>Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Johnson & Johnson (JNJ): Free Stock Analysis Report Netflix, Inc. (NFLX): Free Stock Analysis Report Procter & Gamble Company (The) (PG): Free Stock Analysis Report Amphenol Corporation (APH): Free Stock Analysis Report Ally Financial Inc. (ALLY): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Keep
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Keep
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Procter & Gamble Co.
Analysen zu Procter & Gamble Co.
Datum | Rating | Analyst | |
---|---|---|---|
30.03.2022 | ProcterGamble Neutral | JP Morgan Chase & Co. | |
20.10.2020 | ProcterGamble Sector Perform | RBC Capital Markets | |
23.10.2019 | ProcterGamble buy | Goldman Sachs Group Inc. | |
30.07.2019 | ProcterGamble Sector Perform | RBC Capital Markets | |
24.04.2019 | ProcterGamble Overweight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
23.10.2019 | ProcterGamble buy | Goldman Sachs Group Inc. | |
24.04.2019 | ProcterGamble Overweight | Barclays Capital | |
14.12.2017 | ProcterGamble Buy | Deutsche Bank AG | |
27.04.2017 | ProcterGamble Hold | Stifel, Nicolaus & Co., Inc. | |
15.02.2017 | ProcterGamble kaufen | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
30.03.2022 | ProcterGamble Neutral | JP Morgan Chase & Co. | |
20.10.2020 | ProcterGamble Sector Perform | RBC Capital Markets | |
30.07.2019 | ProcterGamble Sector Perform | RBC Capital Markets | |
24.04.2019 | ProcterGamble Neutral | Credit Suisse Group | |
23.04.2019 | ProcterGamble Neutral | Goldman Sachs Group Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Procter & Gamble Co. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen